Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Cash Flow Quality Index
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Quality Index of 3.03x as of September 2025. Operating cash flow of CN¥399.43 Million exceeds net income of CN¥131.73 Million, indicating high earnings quality where cash backs reported profits. Also explore Shenzhen Hepalink Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for Shenzhen Hepalink Pharmaceutical Co Ltd across 18 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002399 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shenzhen Hepalink Pharmaceutical Co Ltd (2007–2025)
Year-by-year earnings quality comparison for Shenzhen Hepalink Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Shenzhen Hepalink Pharmaceutical Co Ltd (002399) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.90x | CN¥1.71 Billion | CN¥349.49 Million | ▲ +39.6% |
| 2024 | 3.51x | CN¥2.19 Billion | CN¥624.92 Million | ▲ +431.7% |
| 2022 | -1.06x | CN¥-756.61 Million | CN¥714.69 Million | ▼ -3627.0% |
| 2021 | -0.03x | CN¥-6.63 Million | CN¥233.38 Million | ▼ -177.8% |
| 2020 | 0.04x | CN¥37.28 Million | CN¥1.02 Billion | ▲ +116.7% |
| 2019 | -0.22x | CN¥-227.60 Million | CN¥1.04 Billion | ▼ -119.3% |
| 2018 | 1.13x | CN¥667.87 Million | CN¥592.18 Million | ▲ +132.7% |
| 2017 | -3.44x | CN¥-407.12 Million | CN¥118.19 Million | ▼ -484.3% |
| 2016 | 0.90x | CN¥346.07 Million | CN¥386.12 Million | ▼ -43.0% |
| 2015 | 1.57x | CN¥893.71 Million | CN¥568.08 Million | ▼ -42.2% |
| 2014 | 2.72x | CN¥912.80 Million | CN¥335.33 Million | ▲ +102.7% |
| 2013 | 1.34x | CN¥420.97 Million | CN¥313.42 Million | ▲ +74.7% |
| 2012 | 0.77x | CN¥473.89 Million | CN¥616.55 Million | ▼ -66.1% |
| 2011 | 2.27x | CN¥1.41 Billion | CN¥618.94 Million | ▲ +673.4% |
| 2010 | 0.29x | CN¥354.86 Million | CN¥1.21 Billion | ▼ -33.2% |
| 2009 | 0.44x | CN¥355.81 Million | CN¥809.06 Million | ▲ +76.9% |
| 2008 | 0.25x | CN¥40.13 Million | CN¥161.39 Million | ▲ +22.4% |
| 2007 | 0.20x | CN¥13.85 Million | CN¥68.16 Million | — |